See more : Optimi Health Corp. (OPTHF) Income Statement Analysis – Financial Results
Complete financial analysis of Ador Multiproducts Limited (ADORMUL.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ador Multiproducts Limited, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Alamo Group Inc. (ALG) Income Statement Analysis – Financial Results
- Pinnacle Bancshares, Inc. (PCLB) Income Statement Analysis – Financial Results
- Avidian Gold Corp. (AVG.V) Income Statement Analysis – Financial Results
- Cruzani, Inc. (CZNI) Income Statement Analysis – Financial Results
- Showa Holdings Co., Ltd. (5103.T) Income Statement Analysis – Financial Results
Ador Multiproducts Limited (ADORMUL.BO)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: http://www.adormultiproducts.com
About Ador Multiproducts Limited
Ador Multiproducts Ltd. engages in the manufacture and sale of personal care products. It offers personal care products, which includes hand sanitizers, hand wash, skin care and face wash under the brand names of Himalaya Drug Company, Bdel, Apollo Pharmacy Company, and Spar. The company was founded in 1986 and is headquartered in Mumbai, India.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 67.25M | 121.67M | 133.97M | 193.13M | 98.53M | 72.79M | 65.72M | 66.88M | 57.97M | 81.63M | 99.28M | 115.95M | 111.89M | 106.82M | 120.48M |
Cost of Revenue | 69.98M | 96.71M | 98.65M | 128.13M | 73.63M | 54.09M | 48.30M | 45.45M | 41.46M | 61.33M | 83.32M | 97.00M | 92.73M | 86.16M | 98.56M |
Gross Profit | -2.72M | 24.96M | 35.32M | 65.00M | 24.89M | 18.70M | 17.42M | 21.43M | 16.52M | 20.30M | 15.97M | 18.94M | 19.16M | 20.65M | 21.92M |
Gross Profit Ratio | -4.05% | 20.52% | 26.36% | 33.65% | 25.27% | 25.69% | 26.51% | 32.05% | 28.49% | 24.87% | 16.08% | 16.34% | 17.12% | 19.33% | 18.19% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 600.02K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 5.43M | 30.30M | 21.50M | 14.15M | 9.18M | 2.58M | 1.85M | 3.36M | 3.10M | 3.86M | 3.96M | 2.25M | 1.92M | 0.00 | 0.00 |
Selling & Marketing | 1.52M | 26.77M | 24.79M | 9.65M | 6.90M | 163.96K | 2.35M | 556.52K | 103.03K | 309.65K | 222.85K | 282.24K | 160.16K | 0.00 | 0.00 |
SG&A | 6.96M | 57.07M | 46.29M | 23.80M | 16.08M | 2.74M | 4.20M | 3.92M | 3.20M | 23.56M | 23.89M | 2.53M | 2.08M | 0.00 | 0.00 |
Other Expenses | -9.68M | 2.74M | 2.37M | 1.97M | 4.56M | -2.29M | 20.07K | 1.26M | 847.96K | 518.93K | 426.76K | 99.57K | 1.62M | 0.00 | 0.00 |
Operating Expenses | -2.72M | 116.95M | 102.90M | 79.27M | 57.53M | 33.50M | 26.43M | 34.47M | 27.50M | 29.58M | 31.17M | 25.20M | 20.52M | 17.34M | 15.67M |
Cost & Expenses | 67.25M | 213.66M | 201.55M | 207.41M | 131.17M | 87.59M | 74.72M | 79.92M | 68.96M | 90.91M | 114.49M | 122.20M | 113.25M | 103.50M | 114.24M |
Interest Income | 85.35K | 324.85K | 326.46K | 489.23K | 419.83K | 1.69M | 1.11M | 315.42K | 496.88K | 0.00 | 0.00 | 325.28K | 349.06K | 0.00 | 0.00 |
Interest Expense | 2.80M | 928.75K | 2.04M | 2.65M | 3.64M | 684.15K | 1.80M | 3.28M | 2.94M | 1.72M | 785.87K | 585.92K | 275.28K | 93.00K | 224.00K |
Depreciation & Amortization | 5.30M | 6.87M | 12.42M | 3.85M | 2.60M | 2.03M | 1.21M | 910.35K | 1.83M | 1.48M | 2.32M | 1.96M | 1.68M | 1.51M | 1.35M |
EBITDA | -24.81M | -82.08M | -52.54M | 32.13M | -25.59M | -10.96M | -6.18M | 9.52M | -8.27M | -7.04M | -12.38M | -3.90M | 2.17M | 4.82M | 7.60M |
EBITDA Ratio | -36.89% | -67.94% | -46.13% | -4.07% | -25.61% | -15.13% | -10.15% | -16.24% | -13.80% | -8.92% | -12.53% | -3.36% | 1.94% | 4.51% | 6.30% |
Operating Income | -10.12M | -90.46M | -68.07M | 25.40M | -31.94M | -13.72M | -9.36M | 5.10M | -14.70M | -11.00M | -15.99M | -6.88M | -1.76M | 3.22M | 6.02M |
Operating Income Ratio | -15.05% | -74.35% | -50.81% | 13.15% | -32.42% | -18.86% | -14.25% | 7.62% | -25.36% | -13.48% | -16.11% | -5.94% | -1.57% | 3.01% | 5.00% |
Total Other Income/Expenses | -22.98M | 1.58M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -14.58M | -3.13M | 452.50K | -190.36K | 1.97M | 0.00 | 0.00 |
Income Before Tax | -33.10M | -90.46M | -68.07M | 25.40M | -31.94M | -13.72M | -9.36M | 5.10M | -13.27M | -10.48M | -15.54M | -6.44M | 207.83K | 3.22M | 6.02M |
Income Before Tax Ratio | -49.22% | -74.35% | -50.81% | 13.15% | -32.42% | -18.86% | -14.25% | 7.62% | -22.89% | -12.84% | -15.65% | -5.56% | 0.19% | 3.01% | 5.00% |
Income Tax Expense | 7.10M | 640.67K | 1.26M | 10.45M | -3.42M | -101.27K | 320.57K | 2.32M | -4.46M | -3.41M | -4.93M | -1.98M | -152.77K | 977.00K | 1.80M |
Net Income | -40.20M | -91.10M | -69.33M | 14.95M | -28.53M | -13.62M | -9.68M | 2.77M | -8.80M | -7.07M | -10.61M | -4.47M | 360.60K | 2.24M | 4.22M |
Net Income Ratio | -59.78% | -74.87% | -51.75% | 7.74% | -28.95% | -18.72% | -14.74% | 4.15% | -15.19% | -8.67% | -10.68% | -3.85% | 0.32% | 2.10% | 3.50% |
EPS | -8.60 | -19.49 | -14.83 | 3.20 | -7.53 | -4.24 | -3.38 | 0.97 | -3.21 | -2.62 | -4.06 | -1.71 | 0.14 | 0.89 | 1.80 |
EPS Diluted | -8.60 | -19.49 | -14.83 | 3.20 | -7.53 | -4.24 | -3.38 | 0.97 | -3.21 | -2.51 | -4.06 | -1.71 | 0.14 | 0.85 | 1.67 |
Weighted Avg Shares Out | 4.67M | 4.67M | 4.67M | 4.67M | 3.79M | 3.21M | 2.86M | 2.86M | 2.74M | 2.70M | 2.61M | 2.61M | 2.61M | 2.52M | 2.34M |
Weighted Avg Shares Out (Dil) | 4.67M | 4.67M | 4.67M | 4.67M | 3.79M | 3.21M | 2.86M | 2.86M | 2.74M | 2.82M | 2.61M | 2.61M | 2.61M | 2.64M | 2.53M |
Source: https://incomestatements.info
Category: Stock Reports